Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Laboratory measurement of UVA irradiation levels employed in clinical corneal collagen cross-linking devices

Poster Details

First Author: I.Kontari GREECE

Co Author(s):    G. Asimellis   A. Kanellopoulos           

Abstract Details



Purpose:

To independently confirm measurement of the irradiation levels used in clinical corneal collagen cross-Linking devices

Setting:

Laservision.gr Eye Institute, Athens, Greece

Methods:

Laboratory-graded UVA digital light radiometers (DigiProbe, sglux SolGel Technologies GmbH, Berlin, Germany) were employed to independently measure UVA (365 nm - centered) irradiation levels in four CXL devices in current clinical use: (KXL I and KXL II, Avedro, Waltham MA, Vega, CSO, Scandicci Firenze, Italy, and the UVX 2000, IROC Innocross AG, Zug, Switzerland) were measured. The per-manufactured suggested working distances and other environmental parameters were observed. Temporal variations during measurement, as well as comparison of averages between different-session measurements were recorded.

Results:

Average fluence measured were, for the KXL system, 29.5 ± 1.3 mW/cm2 (manufacturer-released, 30 mW/cm2), for the Vega system, 2.8 ± 0.3 mW/cm2 (manufacturer-released, 3 mW/cm2), and for the UVX system, 2.6± 0.7 mW/cm2

Conclusions:

Independent, laboratory investigation of clinical CXL devices reveals that the KXL systems are closely matched to manufacturer-released fluence values with little intra-operating deviations FINANCIAL INTEREST: One of more of the authors... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to Poster listing